Clinical Trial

Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
To Evaluate the Safety and Pharmacokinetics of Pranlukast hydrate in Healthy Adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-14.
Trial Details
NCT Number NCT07231861
Lead Sponsor AJU Pharm Co., Ltd.
Conditions Bronchial Asthma, Perennial Allergic Rhinitis
Enrollment 60 participants
Start Date 2025-12
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-19